Buy Aridis Pharmaceuticals Stock | ARDS Stock Price & Latest News | Public
ARDS

Aridis Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About ARDS

    Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-105, AR-101, AR-401, AR-201, and AR-501. The company w...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.24
    -0.49
    -0.73
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.55

    Actual EPS
    Q4 2020

    Stats

    Market Cap$68,73M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$10.18
    1 Year Low$3.80
    Open$7.16
    High$7.16
    Low$7.05

    Buy any stock with any amount of money.

    Download the App
    Download the app